Glycyrrhizin Attenuates MPTP Neurotoxicity in Mouse and $MPP^+$-Induced Cell Death in PC12 Cells

  • Kim, Yun-Jeong (Department of Pharmacology, College of Medicine, Chung-Ang University) ;
  • Lee, Chung-Soo (Department of Pharmacology, College of Medicine, Chung-Ang University)
  • Published : 2008.04.30

Abstract

The present study examined the inhibitory effect of licorice compounds glycyrrhizin and a metabolite $18{\beta}$-glycyrrhetinic acid on the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse and on the 1-methyl-4-phenylpyridinium ($MPP^+$)-induced cell death in differentiated PC12 cells. MPTP treatment increased the activities of total superoxide dismutase, catalase and glutathione peroxidase and the levels of malondialdehyde and carbonyls in the brain compared to control mouse brain. Co-administration of glycyrrhizin (16.8 mg/kg) attenuated the MPTP effect on the enzyme activities and formation of tissue peroxidation products. In vitro assay, licorice compounds attenuated the $MPP^+$-induced cell death and caspase-3 activation in PC12 cells. Glycyrrhizin up to $100{\mu}M$ significantly attenuated the toxicity of $MPP^+$. Meanwhile, $18{\beta}$-glycyrrhetinic acid showed a maximum inhibitory effect at $10{\mu}M$; beyond this concentration the inhibitory effect declined. Glycyrrhizin and $18{\beta}$-glycyrrhetinic acid attenuated the hydrogen peroxide- or nitrogen species-induced cell death. Results from this study indicate that glycyrrhizin may attenuate brain tissue damage in mice treated with MPTP through inhibitory effect on oxidative tissue damage. Glycyrrhizin and $18{\beta}$-glycyrrhetinic acid may reduce the $MPP^+$ toxicity in PC12 cells by suppressing caspase-3 activation. The effect seems to be ascribed to the antioxidant effect.

Keywords

References

  1. Aebi H. Catalase in vitro. Methods Enzymol 105: 121-126, 1984 https://doi.org/10.1016/S0076-6879(84)05016-3
  2. Agarwal MK, Iqbal M, Athar M. Inhibitory effect of 18$\beta$-glycyrrhetinic acid on 12-O-tetradecanoyl phorbol-13-acetate- induced cutaneous oxidative stress and tumor promotion in mice. Redox Rep 10: 151-157, 2005 https://doi.org/10.1179/135100005X57346
  3. Bonuccelli U, Del Dotto P. New pharmacological horizons in the treatment of Parkinson disease. Neurology 67 (7 Suppl. 2): S30-S38, 2006 https://doi.org/10.1212/WNL.67.7_suppl_2.S30
  4. Cassarino DS, Fall CP, Swerdlow RH, Smith TS, Halvorsen EM, Miller SW, Parks JP, Parker Jr WD, Bennet Jr JP. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. Biochim Biophys Acta 1362: 77-80, 1997 https://doi.org/10.1016/S0925-4439(97)00070-7
  5. Cassarino DS, Parks JK, Parker WD Jr, Bennett JP Jr. The Parkinsonian neurotoxin MPP$^{+}$ opens the mitochondrial permeability transition pore and releases cytochrome c in isolated mitochondria via an oxidative mechanism. Biochim Biophys Acta 1453: 49-62, 1999 https://doi.org/10.1016/S0925-4439(98)00083-0
  6. Fleury C, Mignotte B, Vayssière J-L. Mitochondrial reactive oxygen species in cell death signaling. Biochimie 84: 131-141, 2002 https://doi.org/10.1016/S0300-9084(02)01369-X
  7. Flohe L, Gunzler WA. Assays of glutathione peroxidase. Methods Enzymol 105: 114-121, 1984 https://doi.org/10.1016/S0076-6879(84)05015-1
  8. Gutteridge JMC, Rowley DA, Halliwell B. Superoxide dependent formation of hydroxyl radicals and lipid peroxidation in the presence of iron salts. Detection of 'catalytic' iron and antioxidant activity in extracellular fluids. Biochem J 206: 605-609, 1982
  9. Hung HC, Lee EHY. MPTP produces differential oxidative stress and antioxidative responses in the nigrostriatal and mesolimbic dopaminergic pathways. Free Radic Biol Med 24: 76-84, 1998 https://doi.org/10.1016/S0891-5849(97)00206-2
  10. Ishiwata S, Nakashita K, Ozawa Y, Niizeki M, Nozaki S, Tomioka Y, Mizugaki M. Fas-mediated apoptosis is enhanced by glycyrrhizin without alteration of caspase-3-like activity. Biol Pharm Bull 22: 1163-1166, 1999 https://doi.org/10.1248/bpb.22.1163
  11. Jenner P. Oxidative stress in Parkinson's disease. Ann Neurol 53 (suppl 3): S26-S38, 2003 https://doi.org/10.1002/ana.10483
  12. Jeong HG, You HJ, Park SJ, Moon AR, Chung YC, Kang SK, Chun HK. Hepatoprotective effects of 18$\beta$-glycyrrhetinic acid on carbon tetrachloride-induced liver injury: inhibition of cytochrome P450 2E1 expression. Pharmacol Res 46: 221-227, 2002 https://doi.org/10.1016/S1043-6618(02)00121-4
  13. Kadota T, Yamaai T, Saito Y, Akita Y, Kawashima S, Moroi K, Inagaki N, Kadota K. Expression of dopamine transporter at the tips of growing neurites of PC12 cells. J Histochem Cytochem 44: 989-996, 1996 https://doi.org/10.1177/44.9.8773564
  14. Kim R, Emi M, Tanabe K. Role of mitochondria as the gardens of cell death. Cancer Chemother Pharmacol 57: 545-553, 2006 https://doi.org/10.1007/s00280-005-0111-7
  15. Kinjo J, Hirakawa T, Tsuchihashi R, Nagao T, Okawa M, Nohara T, Okabe H. Hepatoprotective constituents in plants. 14. Effects of soyasapogenol B, sophoradiol, and their glucuronides on the cytotoxicity of tert-butyl hydroperoxide to HepG2 cells. Biol Pharm Bull 26: 1357-1360, 2003 https://doi.org/10.1248/bpb.26.1357
  16. Lee CS, Kim YJ, Ko HH, Han ES. Modulation of 1-methyl-4- phenylpyridinium-induced mitochondrial dysfunction and cell death by KATP channel block. J Neural Transm 114: 297-305, 2007 https://doi.org/10.1007/s00702-006-0594-3
  17. Lee DH, Han YS, Han ES, Bang H, Lee CS. Differential involvement of intracellular Ca$^{2+}$ in 1-methyl-4-phenylpyridinium- or 6-hydroxydopamine-induced cell viability loss in PC12 cells. Neurochem Res 31: 851-860, 2006 https://doi.org/10.1007/s11064-006-9088-9
  18. Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz A-G, Ahn B-W, Shaltiel S, Stadman ER. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186: 464-478, 1990 https://doi.org/10.1016/0076-6879(90)86141-H
  19. Makino T, Tsubouchi R, Murakami K, Haneda M, Yoshino M. Generation of reactive oxygen species and induction of apoptosis of HL60 cells by ingredients of traditional herbal medicine, Sho-saiko-to. Basic Clin Pharmacol Toxicol 98: 401-415, 2006 https://doi.org/10.1111/j.1742-7843.2006.pto_328.x
  20. Matsui S, Matsumoto H, Sonoda Y, Ando K, Aizu-Yokota E, Sato T, Kasahara T. Glycyrrhizin and related compounds down- regulate production of inflammatory chemokines IL-8 and eotaxin 1 in a human lung fibroblast cell line. Int Immunopharmacol 15: 1633-1644, 2004
  21. McCord JM, Fridovich I. Superoxide dismutase. Enzymatic function for erythrocuprein (hemocuprein). J Biol Chem 244: 6049-6055, 1969
  22. Mignotte B, Vayssière JL. Mitochondria and apoptosis. Eur J Biochem 252: 1-15, 1998. https://doi.org/10.1046/j.1432-1327.1998.2520001.x
  23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55-63, 1983 https://doi.org/10.1016/0022-1759(83)90303-4
  24. Muijsers RBR, Folkerts G, Henricks PA, Sadeghi-Hashjin G, Nijkamp FP. Peroxynitrite: a two faced metabolite of nitric oxide. Life Sci 60: 1833-1845, 1997 https://doi.org/10.1016/S0024-3205(96)00651-0
  25. Nagai T, Egashira T, Yamanaka Y, Kohno M. The protective effect of glycyrrhizin against injury of the liver caused by ischemia-reperfusion. Arch Environ Contam Toxicol 20: 432-436, 1991 https://doi.org/10.1007/BF01064416
  26. Olanow CW, Tatton WG. Etiology and pathogenesis of Parkinson's disease. Annu Rev Neurosci 22: 123-144, 1999 https://doi.org/10.1146/annurev.neuro.22.1.123
  27. Przedborski S, Jackson-Lewis V. Mechanism of MPTP toxicity. Mov Disord 13: 35-38, 1998 https://doi.org/10.1002/mds.870131306
  28. Schulz JB, Matthews RT, Klockgether T, Dichgans J, Beal MF. The role of mitochondrial dysfunction and neuronal nitric oxide in animal models of neurodegenerative diseases. Mol Cell Biochem 174: 193-197, 1997 https://doi.org/10.1023/A:1006852306789
  29. Shibata S. A drug over the millennia: pharmacognosy, chemistry, and pharmacology of licorice. Yakugaku Zasshi 120: 849-862, 2000
  30. Tatton WG, Chalmers-Redman RME, Ju WJH, Mammen M, Carlile GW, Pong AW, Tatton NA. Propargylamines induce antiapoptotic new protein synthesis in serum-and nerve growth factor (NGF)-withdrawn, NGF-differentiated PC-12 cells. J Pharmacol Exp Ther 301: 753-764, 2002 https://doi.org/10.1124/jpet.301.2.753
  31. Yokozawa T, Liu ZW, Chen CP. Protective effects of Glycyrrhizae radix extract and its compounds in a renal hypoxia (ischemia)- reoxygenation (reperfusion) model. Phytomedicine 6: 439-445, 2000 https://doi.org/10.1016/S0944-7113(00)80072-0
  32. Yoshikawa M, Toyohara M, Ueda S, Shirol A, Takeuchi H, Nishiyama T, Yamada T, Fukui H, Ishizaka S. Glycyrrhizin inhibits TNF-induced, but not Fas-mediated, apoptosis in the human hepatoblastoma line HepG2. Biol Pharm Bull 22: 951-955, 1999 https://doi.org/10.1248/bpb.22.951
  33. Zheng QZ, Lou YJ. Pathologic characteristics of immunologic injury in primary cultured rat hepatocytes and protective effect of glycyrrhizin in vitro. Acta Pharmacol Sin 24: 771-777, 2003